quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:49:17·127d
SECFiling
Veru Inc. logo

SEC Form 10-K filed by Veru Inc.

VERU· Veru Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • VERU
    Veru Inc.
    Health Care

Recent analyst ratings

  • Dec 18UpdateCanaccord Genuity$25.00
  • May 14UpdateB. Riley Securities$5.00
  • Mar 28UpdateRaymond James$3.00
  • Jun 7UpdateJefferies$1.00

Related

  • SEC8d
    SEC Form EFFECT filed by Veru Inc.
  • SEC8d
    SEC Form EFFECT filed by Veru Inc.
  • SEC16d
    SEC Form S-3 filed by Veru Inc.
  • SEC16d
    SEC Form S-3 filed by Veru Inc.
  • SEC41d
    Veru Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • PR45d
    Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
  • PR63d
    Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
  • SEC71d
    SEC Form 10-Q filed by Veru Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022